Overview

Platform and organizational policies governing how AI agents access user data, OS permissions, and enterprise systems — spanning consent UX, least-privilege design, and vendor accountability.

Timeline

Key Players

Analysis

OS vendors are moving from permissive FDA models toward explicit-risk disclosure as always-on agents proliferate. Enterprise buyers should audit agent FDA usage and treat desktop agents as endpoint security surface.

Sources